These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 3003304

  • 1. Non-modulating essential hypertension: a subset particularly responsive to converting enzyme inhibitors.
    Williams GH, Hollenberg NK.
    J Hypertens Suppl; 1985 Nov; 3(2):S81-7. PubMed ID: 3003304
    [Abstract] [Full Text] [Related]

  • 2. Volume control and altered renal and adrenal responsiveness to angiotensin in essential hypertension: implications for treatment with converting enzyme inhibition.
    Hollenberg NK, Williams GH.
    J Hypertens Suppl; 1983 Oct; 1(1):119-28. PubMed ID: 6100600
    [Abstract] [Full Text] [Related]

  • 3. Converting enzyme inhibitors normalize the reduced adrenal responsiveness to angiotensin II in essential hypertension.
    Williams GH, Hollenberg NK.
    J Hypertens Suppl; 1984 Dec; 2(2):S43-7. PubMed ID: 6100876
    [Abstract] [Full Text] [Related]

  • 4. Renal abnormalities in nonmodulating essential hypertension.
    Williams GH, Moore TJ, Hollenberg NK.
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):39-44. PubMed ID: 3037888
    [Abstract] [Full Text] [Related]

  • 5. Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
    Hollenberg NK, Williams GH.
    Kidney; 1988 Nov; 21(3):13-8. PubMed ID: 11538850
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A, Pedrinelli R, Arzilli F, Abdel-Haq B, Magagna A, Lucarini A, Graziadei L, Nuccorini A, Taddei S.
    Int J Clin Pharmacol Res; 1985 Nov; 5(6):429-38. PubMed ID: 3005182
    [Abstract] [Full Text] [Related]

  • 7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 8. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z, Armaly Z, Nakhoul F, Hoffman A.
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [Abstract] [Full Text] [Related]

  • 9. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M, Brunner HR.
    Exp Nephrol; 1996 Jun; 4 Suppl 1():41-6. PubMed ID: 9001896
    [Abstract] [Full Text] [Related]

  • 10. Dysregulation of aldosterone secretion and its relationship to the pathogenesis of essential hypertension.
    Williams GH, Moore TJ, Hollenberg NK.
    Endocrinol Metab Clin North Am; 1991 Jun; 20(2):423-47. PubMed ID: 1879402
    [Abstract] [Full Text] [Related]

  • 11. [ACE-inhibitors in renal protection].
    Barna I.
    Orv Hetil; 2006 Jun 04; 147(22):1019-23. PubMed ID: 16913091
    [Abstract] [Full Text] [Related]

  • 12. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP, Schnackenberg CG.
    Semin Nephrol; 2000 Sep 04; 20(5):417-25. PubMed ID: 11022893
    [Abstract] [Full Text] [Related]

  • 13. Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients.
    Patel TV, Williams GH, Fisher ND.
    J Hypertens; 2008 Jul 04; 26(7):1353-9. PubMed ID: 18551010
    [Abstract] [Full Text] [Related]

  • 14. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
    Andersen RS, Christensen S.
    Ugeskr Laeger; 2001 Dec 10; 163(50):7036-9. PubMed ID: 11794033
    [Abstract] [Full Text] [Related]

  • 15. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
    Burnier M.
    Drugs; 2002 Dec 10; 62 Spec No 1():21-9. PubMed ID: 12036386
    [Abstract] [Full Text] [Related]

  • 16. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH, Reams GP.
    J Am Soc Nephrol; 1990 Nov 10; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [Abstract] [Full Text] [Related]

  • 17. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL, Henik RA, Stepien RL.
    Vet Ther; 2002 Nov 10; 3(2):157-66. PubMed ID: 19750747
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.